Abstract
As with most therapies for differentiated thryoid carcinoma, there is little consensus about optimal use of postoperative adjuvant therapies or long-term follow-up strategies. However, an increasing body of data indicates that most patients can benefit from postoperative radioiodine ablation followed by thyroid hormone suppression therapy. An approach to long-term monitoring and therapy is provided, including the use of strategies dependent upon the extent of the patient's initial disease.
Original language | English (US) |
---|---|
Pages (from-to) | 30-33 |
Number of pages | 4 |
Journal | Seminars in Surgical Oncology |
Volume | 16 |
Issue number | 1 |
DOIs | |
State | Published - 1999 |
Keywords
- Combined modality therapy
- Follicular adenocarcinoma
- Levothyroxine
- Papillary carcinoma
- Radiotherapy dosage
- Thyroid neoplasms
ASJC Scopus subject areas
- Surgery
- Oncology